Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis
Cancers of the small bowel could account for less than 5% of all gastrointestinal malignancies. Of these tumors, adenocarcinomas were the major histologic subtype and generally carried a poor prognosis. High expression of vascular epithelial growth factor (VEGF) could be seen in small bowel adenocar...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-05-01
|
| Series: | Rare Tumors |
| Online Access: | https://doi.org/10.1177/2036361318825413 |